Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cutter Laboratories was a historic American pharmaceutical company based in Berkeley, California, specializing in biologics, vaccines, and blood-fractionation products. Founded in 1897, the company played a critical role in the early 20th-century medical landscape, notably as one of the primary manufacturers of the Salk polio vaccine. The company is frequently cited in medical history for the 1955 Cutter Incident, where a manufacturing failure led to the distribution of vaccine batches containing live virus. In 1974, Cutter was acquired by the German conglomerate Bayer AG, which utilized the acquisition to establish a major presence in the U.S. biologics market. Bayer eventually retired the Cutter brand name in the mid-1990s, fully integrating its operations into Bayer's healthcare business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cutter.